|[September 05, 2013]
Research and Markets: Kidney Disease - Pipeline Review, H2 2013
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/xg2w2l/kidney_disease)
has announced the addition of the "Kidney
Disease - Pipeline Review, H2 2013" report to their offering.
'Kidney Disease - Pipeline Review, H2 2013', provides an overview of the
indication's therapeutic pipeline. This report provides information on
the therapeutic development for Kidney Disease, complete with latest
updates, and special features on late-stage and discontinued projects.
It also reviews key players involved in the therapeutic development for
- A snapshot of the global therapeutic scenario for Kidney Disease.
- A review of the Kidney Disease products under development by companies
and universities/research institutes based o information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging
from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and
- Coverage of the Kidney Disease pipeline on the basis of route of
administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Bristol-Myers Squibb Company
Baxter International Inc.
Eli Lilly and Company
Quark Pharmaceuticals, Inc.
Merck & Co., Inc.
Chugai Pharmaceutical Co. Ltd
LEO Pharma A/S
Zydus Cadila Healthcare Limited
Hadasit Medical Research Services & Development Ltd
Cyclacel Pharmaceuticals Inc.
OPKO Health, Inc.
Celldex Therapeutics, Inc.
and many more...
For more information visit http://www.researchandmarkets.com/research/xg2w2l/kidney_disease
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]